Charles River Laboratories

What makes the Charles River Biotech Symposium stand out? Be part of the meeting where critical challenges are solved, connections are made, and progress accelerates. Because time is of the essence. Because every moment matters. Because patients are waiting. Register now to move science forward—together. https://okt.to/RO0HpC #BiotechSymposium #DrugDevelopment #Preclinical #Biotechnology #RegulatoryStrategy #science

Biotech firsts are happening—are you paying attention? Mary Parker chats with NanoPalm | نانو بالم CEO Dr. Ali Alhasan and Charles River’s Dr. Ramin B. about the first gene therapy trial in Saudi Arabia, startup innovation, and the future of rare disease treatment. https://okt.to/3Bd2Yx #biotech #drugdiscovery #drugresearch #genetherapy

🧪 The complex landscape of immunotherapy continues to evolve, from platform approaches to process development to machine learning and in-line analytics. Learn the latest techniques with this webinar on demand + eBook on Next-gen immunotherapy: a guide for CGT developers. https://okt.to/KEx83N

We’re proud to be a partner of GentiBio as they reach the next milestone of bringing their engineered Tregs to the clinic in order to transform treatment for patients with Type 1 Diabetes.

Our latest #EurekaBlog post explores a cutting-edge, 3Rs-aligned quarantine strategy for incoming mouse and rat models. This strategy speeds up health monitoring while reducing stress and improving outcomes. Read the full post to learn how this efficient quarantine process protects animal welfare and enhances research quality: https://okt.to/zOI2rf

Move confidently toward commercialization with a team that provides strategic guidance with evolving regulations, proven platforms, and accelerated timelines. Discover how we’re raising the bar on CGT development at our Memphis CDMO site. https://okt.to/pjgZsK

Mark Your Calendar: September 16th! Planning ahead for autumn? Be sure to add the Cell & Gene Therapy Summit, London, to your list of priorities: https://okt.to/FKbirs Explore the agenda, including: - The Patient Story - Regulatory Insights from Claire Kerridge, MHRA - State of the CGT Industry with Rob Allen, Dark Horse Consulting Group Inc. - The CGT Journey: Discovery to Commercialization - Investor and Market Insights - CGT Company Presentations Join us and gain expert insights to help you navigate critical CGT challenges. #CGTSummit #cellandgenetherapy #concepttocure #everymomentmatters

Congratulations to the Myrtelle team on this exciting announcement. We are proud to be supporting your work and to be part of the journey, bringing hope to the patients and families affected by Canavan disease.

“When every day, every hour, every minute makes a difference in saving lives, the Charles River team is excited and privileged to continue to support Myrtelle at this pivotal stage. Myrtelle’s groundbreaking program exemplifies the progress gene therapy has made from concept toward commercial reality, and we’re proud to be part of that journey, bringing hope to the patients and families affected by Canavan disease.” - Kerstin Dolph, CSVP Global Manufacturing

During the Viral Safety and Viral Clearance Summit, we invited attendees and our customers for a site tour in Cologne, Germany. Our facility offers comprehensive services and support for viral clearance from study design, process scale-down support, and execution to generating reports that meet regulatory expectations under GLP. https://okt.to/VC5i48